BUB1B Promotes Extrahepatic Cholangiocarcinoma Progression

Total Page:16

File Type:pdf, Size:1020Kb

BUB1B Promotes Extrahepatic Cholangiocarcinoma Progression Jiao et al. Cell Death and Disease (2021) 12:63 https://doi.org/10.1038/s41419-020-03234-x Cell Death & Disease ARTICLE Open Access BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK/c-Jun pathways Chen Yu Jiao1, Qin Chao Feng1,2, Chang Xian Li1,DongWang1,ShengHan1, Yao Dong Zhang1,WangJieJiang1, Jiang Chang1,XuehaoWang1 and Xiang Cheng Li1 Abstract Currently, the controversy regarding the expression profile and function of BUB1B in different malignancies still exist. In this project, we aimed to explore the role and molecular mechanism of BUB1B in the progression of extrahepatic cholangiocarcinoma (ECC). The expression levels of BUB1B in human ECC were evaluated by immunohistochemistry, western blot, and real-time PCR. The role and mechanism of BUB1B in CCA cell proliferation and invasion were investigated in both in vitro and in vivo functional studies. To indicate the clinical significance, a tissue microarray was performed on 113 ECC patients, followed by univariate and multivariate analyses. The expression of BUB1B was increased in both human CCA tissues and CCA cells. Results from loss-of-function and gain-of-function experiments suggested that the inhibition of BUB1B decreased the proliferation and invasiveness of CCA cells in vitro and in vivo, while overexpression of BUB1B achieved the opposite effect. Furthermore, the activation of c-Jun N-terminal kinase-c- Jun (JNK)-c-Jun pathway was regulated by BUB1B. BUB1B regulated the proliferation and invasiveness of CAA cells in a JNK-c-Jun-dependent manner. Clinically, ECC patients with BUB1B high expression had worse overall survival and recurrence-free survival than those with BUB1B low expression. Multivariate analysis identified that BUB1B was an independent predictor for postoperative recurrence and overall survival of ECC patients. In conclusion, BUB1B promoted ECC progression via JNK/c-Jun pathways. These findings suggested that BUB1B could be a potential 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; therapeutic target and a biomarker for predicting prognosis for ECC patients. Introduction Complete surgical resection remains the first choice for Cholangiocarcinoma (CCA), described as a malignancy the treatment of CCA patients. However, the rates of that arises from the epithelial cells of the bile duct, is the resectability and the long-term outcome after these second most common primary hepatobiliary malignancy1. therapies are less than satisfactory because of the high – CCA can be divided into intrahepatic cholangiocarcinoma post-surgical recurrence3 5. Therefore, a clearer under- (ICC) or extrahepatic cholangiocarcinoma (ECC) standing of CCA growth and metastasis mechanisms is according to the tumor location in the biliary tree. ECC is urgently necessary to find the potential therapeutic targets the most common CCA accounting for ~75% of all CCA2. for CCA. BUB1B (BUB1 mitotic checkpoint serine/threonine kinase B) is a member of the spindle assembly checkpoint 6 Correspondence: Chang Xian Li ([email protected])or (SAC) protein family . SAC prevents premature sister Xiang Cheng Li ([email protected]) chromatid separation until all kinetochores are properly 1 Key Laboratory of Liver Transplantation, Chinese Academy of Medical attached to the mitotic spindle during mitosis7. BUB1B Sciences, Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China plays a central role in SAC signaling and stable attach- 2Department of surgery, JiangYuan Hospital Affiliated to Jiangsu Institute of ment of kinetochores to spindle microtubules8,9. Nuclear Medicine, Wuxi, Jiangsu Province, China Although Huang et al.10 reported that the structure of the These authors contributed equally: Chen Yu Jiao, Qin Chao Feng, Chang Xian Li kinase domain of BUB1B in Drosophila melanogaster Edited by S. Tait © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a linktotheCreativeCommons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Official journal of the Cell Death Differentiation Association Jiao et al. Cell Death and Disease (2021) 12:63 Page 2 of 13 folded into a conformation predicted to be catalytically routinely every 3–6 months during the first 5 years of active, more evidence showed that BUB1B, an inactive follow-up and once a year thereafter. Overall survival (OS) pseudokinase, interacts directly with Cdc20, BUB3, and time was defined as the period of time in months from MAD2, constituting the mitotic checkpoint complex, operation to death. Recurrence-free survival time was which inhibit the activity of the anaphase-promoting defined as the period of time in months from operation to complex or cyclosome (APC/C)7,11,12. Accordingly, the recurrence. To validate the clinical significance of BUB1B function of BUB1B is to ensure proper chromosome in CCA, a tissue microarray, as well as the staining of segregation by suppressing the onset of anaphase by BUB1B, was performed on 113 ECC patients. A total of 29 inhibiting APC/C activation13. Given the critical role of ECC samples with matched para-tumor tissues were BUB1B in mitotic checkpoint signaling and chromosome collected for detecting messenger RNA (mRNA) expres- congression, impairment in BUB1B and SAC often results sion. Furthermore, we also detected the mRNA expres- in aneuploidy and chromosomal instability, which can sion of BUB1B in 30 pairs of ICC samples. All CCA tissues – contribute to an increase in cancer incidence14 16. were collected using protocols approved by the Ethics The relationship between BUB1B expression and specific Committee of The First Affiliated Hospital of Nanjing human malignancies remains to be clarified. It has been Medical University, and written informed consent was reported that low expression of BUB1B contributed to the obtained from every patient. initiation and progression of colon adenocarcinoma17,18. However, a large number of reports have demonstrated that Tissue microarray overexpression of BUB1B was associated with progression To validate the clinical significance of BUB1B in ECC, a and recurrence of pancreatic ductal adenocarcinoma, tissue microarray was performed. The details of tissue prostate cancer, hepatocellular carcinoma, and some other microarray have been described in our previous article24. – cancers19 21. BUB1B can mediate anchorage-independent The quantitation of immunostaining for BUB1B was com- survival and growth, thereby facilitating lung adenocarci- pleted by Quick-score (Q-score) based on the intensity and noma dissemination during metastasis22.Moreover, heterogeneity by two independent researchers who were reduction of BUB1B level or inhibition of BUB1B kinase blinded regarding patient details. The positive rates were activity in human cancer cells resulted in massive chro- scored as 0 point (0–5%), 1 point (6–35%), 2 points mosome loss and apoptotic cell death23.TheCancerGen- (36–70%), and 3 points (71–100%). The score of the ome Atlas (TCGA) database data showed that the staining intensity was presented as 0 point (none), 1 point expression of BUB1B in CCA tissues was upregulated. (low), 2 points (medium), and 3 points (high). The Q-score However, the biological function and molecular regulatory was the product of heterogeneity and intensity. The mechanism of BUB1B in CCA remain unclear. Therefore, it expression was defined as high when the Q-score were >4. was worthwhile to further explore the roles and precise mechanisms of BUB1B in CCA. Cell culture and transfection In the current study, we aimed to investigate the roles CCA cell lines (RBE, QBC939, HCCC9810, and and mechanisms of BUB1B in CCA and then explore its HUCCT) and normal bile duct epithelial cell line (HiBEC) prognostic prediction value. We first detected the were obtained from the Cell Bank of the Chinese Acad- expression profile of BUB1B in CCA tissues and cell lines. emy of Science (Shanghai, China). These cell lines were Then, we investigated the functional role of BUB1B in cell cultured in Dulbecco’s modified Eagle’s medium (Gibco, proliferation and invasiveness of CCA and further USA) with 10% fetal bovine serum (Biological Industries, explored the underlying mechanism. After that, the clin- Israel), penicillin/streptomycin 100 U/ml at 37 °C in a 5% ical significance of BUB1B in ECC patients was explored. CO2 humidified incubator. The BUB1B-knockdown len- Together, our findings suggested that BUB1B promoted tivirus was designed and produced by Polybrene (Obio CCA proliferation and invasiveness, as well as a candidate Technology) using pLKD-CMV-G and PR-U6-shRNA biomarker of prognostic prediction and a potential ther- vector. BUB1B overexpression plasmid was designed by apeutic target for ECC patients. Shanghai Genechem Co., Ltd (GV144 vector, XhoI/ BamHI enzyme cleavage, seq: Materials and methods 5′-GTCCGGACTCAGATCTCGAGCTATGGCGG
Recommended publications
  • Identification of Hub Genes Involved in the Occurrence and Development of Hepatocellular Carcinoma Via Bioinformatics Analysis
    ONCOLOGY LETTERS 20: 1695-1708, 2020 Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis NINGNING MI1,2*, JIE CAO1-6*, JINDUO ZHANG2-5, WENKANG FU1-5, CHONGFEI HUANG1-5, LONG GAO1-5, PING YUE2-5, BING BAI2-5, YANYAN LIN1-5, WENBO MENG1-5 and XUN LI4,5,7 1The First Clinical Medical School, Lanzhou University; 2Department of Special Minimally Invasive Surgery, The First Hospital of Lanzhou University; 3Institute of Genetics, School of Basic Medical Sciences, Lanzhou University; 4Gansu Province Institute of Hepatopancreatobiliary; 5Gansu Province Key Laboratory Biotherapy and Regenerative Medicine; 6Laboratory Department; 7The Fifth Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China Received September 28, 2019; Accepted May 7, 2020 DOI: 10.3892/ol.2020.11752 Abstract. Hepatocellular carcinoma (HCC) is a heterogeneous cyclin B1 (CCNB1), cell-division cycle protein 20 (CDC20), malignancy, which is a major cause of cancer morbidity and cyclin-dependent kinase 1, BUB1 mitotic checkpoint serine/ mortality worldwide. Thus, the aim of the present study was threonine kinase β (BUB1B), cyclin A2, nucleolar and spindle to identify the hub genes and underlying pathways of HCC associated protein 1, ubiquitin‑conjugating enzyme E2 C via bioinformatics analyses. The present study screened three (UBE2C) and ZW10 interactor. Furthermore, upregulated datasets, including GSE112790, GSE84402 and GSE74656 CCNB1, CDC20, BUB1B and UBE2C expression levels from the Gene Expression Omnibus (GEO) database, and indicated worse disease-free and overall survival. Moreover, downloaded the RNA-sequencing of HCC from The Cancer a meta-analysis of tumor and healthy tissues in the Oncomine Genome Atlas (TCGA) database.
    [Show full text]
  • Biallelic TRIP13 Mutations Predispose to Wilms Tumor and Chromosome Missegregation
    Europe PMC Funders Group Author Manuscript Nat Genet. Author manuscript; available in PMC 2017 July 01. Published in final edited form as: Nat Genet. 2017 July ; 49(7): 1148–1151. doi:10.1038/ng.3883. Europe PMC Funders Author Manuscripts Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome missegregation Shawn Yost#1, Bas de Wolf#2, Sandra Hanks#1, Anna Zachariou1, Chiara Marcozzi3,4, Matthew Clarke1, Richarda de Voer2, Banafsheh Etemad2, Esther Uijttewaal2, Emma Ramsay1, Harriet Wylie1, Anna Elliott1, Susan Picton5, Audrey Smith6, Sarah Smithson7, Sheila Seal1, Elise Ruark1, Gunnar Houge8, Jonathan Pines3,4, Geert J.P.L. Kops2,9,10,+, and Nazneen Rahman1,11,+ 1Division of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, London, SM2 5NG, UK 2Hubrecht Institute – KNAW (Royal Netherlands Academy of Arts and Sciences), Uppsalalaan 8, 3584 CT Utrecht, The Netherlands 3The Gurdon Institute and Department of Zoology, University of Cambridge, Cambridge CB2 1QN, UK 4Division of Cancer Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK 5Children's and Adolescent Oncology and Haematology Unit, Leeds General Infirmary, Leeds, LS1 3EX, UK 6Yorkshire Regional Clinical Genetics Service, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK 7Clinical Genetics Service, St Michael's Hospital, Southwell Street, Bristol, BS2 8EG, UK 8Center for Medical Genetics, Haukeland University Hospital, N-5021 Bergen, Norway 9Cancer Genomics Netherlands, Utrecht, The Netherlands 10Center for Molecular 11 Europe PMC Funders Author Manuscripts Medicine, University Medical Center Utrecht, 3584 CG, Utrecht, The Netherlands Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK SM2 5PT, UK # These authors contributed equally to this work.
    [Show full text]
  • Mitotic Arrest Deficient 2 Expression Induces Chemosensitization to a DNA-Damaging Agent, Cisplatin, in Nasopharyngeal Carcinoma Cells
    Research Article Mitotic Arrest Deficient 2 Expression Induces Chemosensitization to a DNA-Damaging Agent, Cisplatin, in Nasopharyngeal Carcinoma Cells Hiu Wing Cheung,1 Dong-Yan Jin,2 Ming-tat Ling,1 Yong Chuan Wong,1 Qi Wang,1 Sai Wah Tsao,1 and Xianghong Wang1 Departments of 1Anatomy and 2Biochemistry, Faculty of Medicine, University of Hong Kong, Hong Kong, China Abstract mitotic checkpoint control, may be associated with tumorigenesis Recently, mitotic arrest deficient 2 (MAD2)–mediated spindle as well as cancer progression. Several regulators of the mitotic checkpoint have been identified checkpoint is shown to induce mitotic arrest in response to DNA damage, indicating overlapping roles of the spindle and most of them are localized to the kinetochore, which is checkpoint and DNA damage checkpoint. In this study, we connected to both the chromosome and the spindle (1). One of investigated if MAD2 played a part in cellular sensitivity to them, mitotic arrest deficient 2 (MAD2), is thought to be a key DNA-damaging agents, especially cisplatin, and whether it was component for a functional mitotic checkpoint because it is regulated through mitotic checkpoint. Using nine nasopha- required for generating the ‘‘wait’’ signal in response to microtubule ryngeal carcinoma (NPC) cell lines, we found that decreased disruption (1). Deletion or down-regulation of MAD2 leads to MAD2 expression was correlated with cellular resistance to mitotic checkpoint inactivation and chromosomal instability (4–6). cisplatin compared with the cell lines with high levels of Down-regulation of MAD2 has also been reported in human MAD2. Exogenous MAD2 expression in NPC cells also cancers such as lung (7), breast (8), nasopharyngeal (9), and ovarian conferred sensitivity to DNA-damaging agents especially carcinomas (10).
    [Show full text]
  • Supplementary Data
    SUPPLEMENTARY DATA A cyclin D1-dependent transcriptional program predicts clinical outcome in mantle cell lymphoma Santiago Demajo et al. 1 SUPPLEMENTARY DATA INDEX Supplementary Methods p. 3 Supplementary References p. 8 Supplementary Tables (S1 to S5) p. 9 Supplementary Figures (S1 to S15) p. 17 2 SUPPLEMENTARY METHODS Western blot, immunoprecipitation, and qRT-PCR Western blot (WB) analysis was performed as previously described (1), using cyclin D1 (Santa Cruz Biotechnology, sc-753, RRID:AB_2070433) and tubulin (Sigma-Aldrich, T5168, RRID:AB_477579) antibodies. Co-immunoprecipitation assays were performed as described before (2), using cyclin D1 antibody (Santa Cruz Biotechnology, sc-8396, RRID:AB_627344) or control IgG (Santa Cruz Biotechnology, sc-2025, RRID:AB_737182) followed by protein G- magnetic beads (Invitrogen) incubation and elution with Glycine 100mM pH=2.5. Co-IP experiments were performed within five weeks after cell thawing. Cyclin D1 (Santa Cruz Biotechnology, sc-753), E2F4 (Bethyl, A302-134A, RRID:AB_1720353), FOXM1 (Santa Cruz Biotechnology, sc-502, RRID:AB_631523), and CBP (Santa Cruz Biotechnology, sc-7300, RRID:AB_626817) antibodies were used for WB detection. In figure 1A and supplementary figure S2A, the same blot was probed with cyclin D1 and tubulin antibodies by cutting the membrane. In figure 2H, cyclin D1 and CBP blots correspond to the same membrane while E2F4 and FOXM1 blots correspond to an independent membrane. Image acquisition was performed with ImageQuant LAS 4000 mini (GE Healthcare). Image processing and quantification were performed with Multi Gauge software (Fujifilm). For qRT-PCR analysis, cDNA was generated from 1 µg RNA with qScript cDNA Synthesis kit (Quantabio). qRT–PCR reaction was performed using SYBR green (Roche).
    [Show full text]
  • 1 Spindle Assembly Checkpoint Is Sufficient for Complete Cdc20
    Spindle assembly checkpoint is sufficient for complete Cdc20 sequestering in mitotic control Bashar Ibrahim Bio System Analysis Group, Friedrich-Schiller-University Jena, and Jena Centre for Bioinformatics (JCB), 07743 Jena, Germany Email: [email protected] Abstract The spindle checkpoint assembly (SAC) ensures genome fidelity by temporarily delaying anaphase onset, until all chromosomes are properly attached to the mitotic spindle. The SAC delays mitotic progression by preventing activation of the ubiquitin ligase anaphase-promoting complex (APC/C) or cyclosome; whose activation by Cdc20 is required for sister-chromatid separation marking the transition into anaphase. The mitotic checkpoint complex (MCC), which contains Cdc20 as a subunit, binds stably to the APC/C. Compelling evidence by Izawa and Pines (Nature 2014; 10.1038/nature13911) indicates that the MCC can inhibit a second Cdc20 that has already bound and activated the APC/C. Whether or not MCC per se is sufficient to fully sequester Cdc20 and inhibit APC/C remains unclear. Here, a dynamic model for SAC regulation in which the MCC binds a second Cdc20 was constructed. This model is compared to the MCC, and the MCC-and-BubR1 (dual inhibition of APC) core model variants and subsequently validated with experimental data from the literature. By using ordinary nonlinear differential equations and spatial simulations, it is shown that the SAC works sufficiently to fully sequester Cdc20 and completely inhibit APC/C activity. This study highlights the principle that a systems biology approach is vital for molecular biology and could also be used for creating hypotheses to design future experiments. Keywords: Mathematical biology, Spindle assembly checkpoint; anaphase promoting complex, MCC, Cdc20, systems biology 1 Introduction Faithful DNA segregation, prior to cell division at mitosis, is vital for maintaining genomic integrity.
    [Show full text]
  • Kinetochores, Microtubules, and Spindle Assembly Checkpoint
    Review Joined at the hip: kinetochores, microtubules, and spindle assembly checkpoint signaling 1 1,2,3 Carlos Sacristan and Geert J.P.L. Kops 1 Molecular Cancer Research, University Medical Center Utrecht, 3584 CG Utrecht, The Netherlands 2 Center for Molecular Medicine, University Medical Center Utrecht, 3584 CG Utrecht, The Netherlands 3 Cancer Genomics Netherlands, University Medical Center Utrecht, 3584 CG Utrecht, The Netherlands Error-free chromosome segregation relies on stable and cell division. The messenger is the SAC (also known as connections between kinetochores and spindle microtu- the mitotic checkpoint) (Figure 1). bules. The spindle assembly checkpoint (SAC) monitors The transition to anaphase is triggered by the E3 ubiqui- such connections and relays their absence to the cell tin ligase APC/C, which tags inhibitors of mitotic exit cycle machinery to delay cell division. The molecular (CYCLIN B) and of sister chromatid disjunction (SECURIN) network at kinetochores that is responsible for microtu- for proteasomal degradation [2]. The SAC has a one-track bule binding is integrated with the core components mind, inhibiting APC/C as long as incorrectly attached of the SAC signaling system. Molecular-mechanistic chromosomes persist. It goes about this in the most straight- understanding of how the SAC is coupled to the kineto- forward way possible: it assembles a direct and diffusible chore–microtubule interface has advanced significantly inhibitor of APC/C at kinetochores that are not connected in recent years. The latest insights not only provide a to spindle microtubules. This inhibitor is named the striking view of the dynamics and regulation of SAC mitotic checkpoint complex (MCC) (Figure 1).
    [Show full text]
  • MAD2 Expression in Oral Squamous Cell Carcinoma and Its Relationship to Tumor Grade and Proliferation
    ANTICANCER RESEARCH 34: 7021-7028 (2014) MAD2 Expression in Oral Squamous Cell Carcinoma and its Relationship to Tumor Grade and Proliferation CLARA RIZZARDI1, LUCIO TORELLI2, MANUELA SCHNEIDER3, FABIOLA GIUDICI4, LORENZO ZANDONA’1, MATTEO BIASOTTO5, ROBERTO DI LENARDA5 and MAURO MELATO6 1Unit of Pathology, Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy; 2Department of Mathematics and Earth Science, University of Trieste, Trieste, Italy; 3Unit of Pathology, ASS n.2 “Isontina”, Gorizia, Italy; 4Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy; 5Unit of Odontology and Stomatology, Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy; 6Scientific Research Institute and Hospital for Pediatrics “Burlo Garofolo”, Trieste, Italy Abstract. Background: Defects in the cell-cycle surveillance might contribute to the chromosomal instability observed in mechanism, called the spindle checkpoint, might contribute human cancers. Molecular analysis of the genes involved in to the chromosomal instability observed in human cancers, the spindle checkpoint has revealed relatively few genetic including oral squamous cell carcinoma. MAD2 and BUBR1 alterations, suggesting that the spindle checkpoint are key components of the spindle checkpoint, whose role in impairment frequently found in many human cancers might oral carcinogenesis and clinical relevance still need to be result from mutations in as yet unidentified checkpoint genes elucidated. Materials and Methods: We analyzed the or altered expression of known checkpoint genes. A better expression of MAD2 in 49 cases of oral squamous cell understanding of this mechanism might provide valuable carcinoma by immunohistochemistry and compared the insights into CIN and facilitate the design of novel findings with clinicopathological parameters, proliferative therapeutic approaches to treat cancer.
    [Show full text]
  • Bub1 Positions Mad1 Close to KNL1 MELT Repeats to Promote Checkpoint Signalling
    ARTICLE Received 14 Dec 2016 | Accepted 3 May 2017 | Published 12 June 2017 DOI: 10.1038/ncomms15822 OPEN Bub1 positions Mad1 close to KNL1 MELT repeats to promote checkpoint signalling Gang Zhang1, Thomas Kruse1, Blanca Lo´pez-Me´ndez1, Kathrine Beck Sylvestersen1, Dimitriya H. Garvanska1, Simone Schopper1, Michael Lund Nielsen1 & Jakob Nilsson1 Proper segregation of chromosomes depends on a functional spindle assembly checkpoint (SAC) and requires kinetochore localization of the Bub1 and Mad1/Mad2 checkpoint proteins. Several aspects of Mad1/Mad2 kinetochore recruitment in human cells are unclear and in particular the underlying direct interactions. Here we show that conserved domain 1 (CD1) in human Bub1 binds directly to Mad1 and a phosphorylation site exists in CD1 that stimulates Mad1 binding and SAC signalling. Importantly, fusion of minimal kinetochore-targeting Bub1 fragments to Mad1 bypasses the need for CD1, revealing that the main function of Bub1 is to position Mad1 close to KNL1 MELTrepeats. Furthermore, we identify residues in Mad1 that are critical for Mad1 functionality, but not Bub1 binding, arguing for a direct role of Mad1 in the checkpoint. This work dissects functionally relevant molecular interactions required for spindle assembly checkpoint signalling at kinetochores in human cells. 1 The Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark. Correspondence and requests for materials should be addressed to G.Z.
    [Show full text]
  • The Closed Form of Mad2 Is Bound to Mad1 and Cdc20 at Unattached Kinetochores
    bioRxiv preprint doi: https://doi.org/10.1101/305763; this version posted April 21, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. The closed form of Mad2 is bound to Mad1 and Cdc20 at unattached kinetochores. Gang Zhang1,2,3 and Jakob Nilsson1 1 The Novo Nordisk Foundation Center for Protein Research, Faculty of health and medical sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark 2 Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266061, China 3 Qingdao Cancer Institute, Qingdao, Shandong 266061, China For correspondence: [email protected] or [email protected] Keywords: Mad2, Cdc20, Kinetochore, Spindle Assembly Checkpoint, Mad1 1 bioRxiv preprint doi: https://doi.org/10.1101/305763; this version posted April 21, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. ABSTRACT The spindle assembly checkpoint (SAC) ensures accurate chromosome segregation by delaying anaphase onset in response to unattached kinetochores. Anaphase is delayed by the generation of the mitotic checkpoint complex (MCC) composed of the checkpoint proteins Mad2 and BubR1/Bub3 bound to the protein Cdc20. Current models assume that MCC production is catalyzed at unattached kinetochores and that the Mad1/Mad2 complex is instrumental in the conversion of Mad2 from an open form (O-Mad2) to a closed form (C-Mad2) that can bind to Cdc20.
    [Show full text]
  • The Aurora B Kinase Activity Is Required for the Maintenance of the Differentiated State of Murine Myoblasts
    Cell Death and Differentiation (2009) 16, 321–330 & 2009 Macmillan Publishers Limited All rights reserved 1350-9047/09 $32.00 www.nature.com/cdd The Aurora B kinase activity is required for the maintenance of the differentiated state of murine myoblasts G Amabile1,2, AM D’Alise1, M Iovino1, P Jones3, S Santaguida4, A Musacchio4, S Taylor5 and R Cortese*,1 Reversine is a synthetic molecule capable of inducing dedifferentiation of C2C12, a murine myoblast cell line, into multipotent progenitor cells, which can be redirected to differentiate in nonmuscle cell types under appropriate conditions. Reversine is also a potent inhibitor of Aurora B, a protein kinase required for mitotic chromosome segregation, spindle checkpoint function, cytokinesis and histone H3 phosphorylation, raising the possibility that the dedifferentiation capability of reversine is mediated through the inhibition of Aurora B. Indeed, here we show that several other well-characterized Aurora B inhibitors are capable of dedifferentiating C2C12 myoblasts. Significantly, expressing drug-resistant Aurora B mutants, which are insensitive to reversine block the dedifferentiation process, indicating that Aurora B kinase activity is required to maintain the differentiated state. We show that the inhibition of the spindle checkpoint or cytokinesis per se is not sufficient for dedifferentiation. Rather, our data support a model whereby changes in histone H3 phosphorylation result in chromatin remodeling, which in turn restores the multipotent state. Cell Death and Differentiation (2009) 16, 321–330; doi:10.1038/cdd.2008.156; published online 31 October 2008 Lineage-restricted cells can be reprogramed to a state Evidence is emerging that the role of Aurora B is not of pluripotency by several different manipulations, including restricted to mitosis and cell division.
    [Show full text]
  • Bipolar Orientation of Chromosomes in Saccharomyces Cerevisiae Is Monitored by Mad1 and Mad2, but Not by Mad3
    Bipolar orientation of chromosomes in Saccharomyces cerevisiae is monitored by Mad1 and Mad2, but not by Mad3 Marina S. Lee and Forrest A. Spencer* McKusick–Nathans Institute of Genetic Medicine, School of Medicine, The Johns Hopkins University, Baltimore, MD 21205 Communicated by Carol W. Greider, The Johns Hopkins University School of Medicine, Baltimore, MD, June 10, 2004 (received for review March 20, 2004) The spindle checkpoint governs the timing of anaphase separation to the kinetochore (9). Vertebrate checkpoint proteins Mad2, of sister chromatids. In budding yeast, Mad1, Mad2, and Mad3 Bub1, Bub3, and BubR1 (a Mad3 homolog with a kinase proteins are equally required for arrest in the presence of damage domain) are also found at kinetochores when kinetochore– induced by antimicrotubule drugs or catastrophic loss of spindle microtubule attachment is prevented by microtubule-depoly- structure. We find that the MAD genes are not equally required for merizing drugs (11, 12). In unaltered prometaphase or during robust growth in the presence of more subtle kinetochore and recovery from antimicrotubule drug treatment, Mad2 localiza- microtubule damage. A mad1⌬ synthetic lethal screen identified 16 tion disappears from kinetochores upon capture by microtu- genes whose deletion in cells lacking MAD1 results in death or slow bules. Once tension is established across sister kinetochores at growth. Eleven of these mad1⌬ genetic interaction partners en- the metaphase plate, Bub1, Bub3, and BubR1 kinetochore code proteins at the kinetochore–microtubule interface. Analysis staining diminishes (11, 12). of the entire panel revealed similar phenotypes in combination In Saccharomyces cerevisiae, Mad1, Mad2, and Mad3 are found with mad2⌬.
    [Show full text]
  • Mph1 Kinetochore Localization Is Crucial and Upstream in The
    4720 Short Report Mph1 kinetochore localization is crucial and upstream in the hierarchy of spindle assembly checkpoint protein recruitment to kinetochores Stephanie Heinrich1, Hanna Windecker1,2, Nicole Hustedt1,3 and Silke Hauf1,* 1Friedrich Miescher Laboratory of the Max Planck Society, Spemannstrasse 39, D-72076 Tuebingen, Germany 2Present address: Septomics Research Centre, Albert-Einstein-Strasse 10, D-07745 Jena, Germany 3Present address: Friedrich Miescher Institute, Maulbeerstrasse 66, CH-4058 Basel, Switzerland *Author for correspondence ([email protected]) Accepted 7 June 2012 Journal of Cell Science 125, 4720–4727 ß 2012. Published by The Company of Biologists Ltd doi: 10.1242/jcs.110387 Summary The spindle assembly checkpoint (SAC) blocks entry into anaphase until all chromosomes have stably attached to the mitotic spindle through their kinetochores. The checkpoint signal originates from unattached kinetochores, where there is an enrichment of SAC proteins. Whether the enrichment of all SAC proteins is crucial for SAC signaling is unclear. Here, we provide evidence that, in fission yeast, recruitment of the kinase Mph1 is of vital importance for a stable SAC arrest. An Mph1 mutant that eliminates kinetochore enrichment abolishes SAC signaling, whereas forced recruitment of this mutant to kinetochores restores SAC signaling. In bub3D cells, the SAC is functional when only Mph1 and the Aurora kinase Ark1, but no other SAC proteins, are enriched at kinetochores. We analyzed the network of dependencies for SAC protein localization to kinetochores and identify a three-layered hierarchy with Ark1 and Mph1 on top, Bub1 and Bub3 in the middle, and Mad3 as well as the Mad1–Mad2 complex at the lower end of the hierarchy.
    [Show full text]